The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors
Official Title:
Study ID: NCT00317928
Brief Summary: Hypothesis: Metformin treatment normalises hormone values and metabolic parameters in women with PCOS. Ovulation is restored and bleeding periods become regular. Fifty women with PCOS (Rotterdam criteria) are randomised to either placebo or metformin for 6 months. After a wash-out period of 3 months, the opposite treatment is given for another 6 months. Measurements are performed before ech treatment period, every second month during treatment and after completing treatment.
Detailed Description:
Minimum Age: 20 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Name: Ditte Trolle, MD
Affiliation: Skejby University Hospital, Aarhus, Denmark
Role: PRINCIPAL_INVESTIGATOR